

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | bile acid and bile salt transport (GO:0015721) | 7.66344016 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 6.63306669 |
| 3 | triglyceride catabolic process (GO:0019433) | 6.54295499 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.25971003 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 6.25971003 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.99979834 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.92738960 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 5.92738960 |
| 9 | acylglycerol catabolic process (GO:0046464) | 5.92314333 |
| 10 | neutral lipid catabolic process (GO:0046461) | 5.92314333 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.88863134 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.88863134 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.88863134 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.76729824 |
| 15 | regulation of protein activation cascade (GO:2000257) | 5.75109980 |
| 16 | complement activation, alternative pathway (GO:0006957) | 5.70850478 |
| 17 | * acute-phase response (GO:0006953) | 5.59119689 |
| 18 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 5.51655880 |
| 19 | ethanol oxidation (GO:0006069) | 5.42560189 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.38635852 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.37638598 |
| 22 | regulation of complement activation (GO:0030449) | 5.25657830 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.14553960 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.98742530 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.95833943 |
| 26 | regulation of sequestering of triglyceride (GO:0010889) | 4.90614154 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.77380610 |
| 28 | protein carboxylation (GO:0018214) | 4.77380610 |
| 29 | omega-hydroxylase P450 pathway (GO:0097267) | 4.77375773 |
| 30 | glyoxylate metabolic process (GO:0046487) | 4.75563461 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.68965640 |
| 32 | bile acid biosynthetic process (GO:0006699) | 4.68289902 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.67579061 |
| 34 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.61767834 |
| 35 | urea metabolic process (GO:0019627) | 4.61723797 |
| 36 | urea cycle (GO:0000050) | 4.61723797 |
| 37 | heme transport (GO:0015886) | 4.49211568 |
| 38 | ethanol metabolic process (GO:0006067) | 4.41162729 |
| 39 | bile acid metabolic process (GO:0008206) | 4.40081345 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.32688279 |
| 41 | cysteine metabolic process (GO:0006534) | 4.32385271 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.29620776 |
| 43 | fatty acid homeostasis (GO:0055089) | 4.27167108 |
| 44 | alpha-linolenic acid metabolic process (GO:0036109) | 4.26028962 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.26003865 |
| 46 | negative regulation of protein activation cascade (GO:2000258) | 4.25370144 |
| 47 | glycerolipid catabolic process (GO:0046503) | 4.21280997 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 4.19686581 |
| 49 | vitamin transmembrane transport (GO:0035461) | 4.13059911 |
| 50 | phospholipid efflux (GO:0033700) | 4.11593867 |
| 51 | opsonization (GO:0008228) | 4.07877168 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.06126703 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.06126703 |
| 54 | primary alcohol metabolic process (GO:0034308) | 4.04777815 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.03312183 |
| 56 | diacylglycerol metabolic process (GO:0046339) | 4.02384142 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 3.99080280 |
| 58 | protein-lipid complex remodeling (GO:0034368) | 3.99080280 |
| 59 | macromolecular complex remodeling (GO:0034367) | 3.99080280 |
| 60 | cellular glucuronidation (GO:0052695) | 3.98644614 |
| 61 | transcytosis (GO:0045056) | 3.97860494 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 3.97243421 |
| 63 | complement activation, classical pathway (GO:0006958) | 3.93831207 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 3.91277885 |
| 65 | amine catabolic process (GO:0009310) | 3.91277885 |
| 66 | regulation of bile acid biosynthetic process (GO:0070857) | 3.88687991 |
| 67 | protein activation cascade (GO:0072376) | 3.85497181 |
| 68 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.84487773 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.83977066 |
| 70 | reverse cholesterol transport (GO:0043691) | 3.83599335 |
| 71 | tyrosine metabolic process (GO:0006570) | 3.82556093 |
| 72 | fibrinolysis (GO:0042730) | 3.82536368 |
| 73 | complement activation (GO:0006956) | 3.80112279 |
| 74 | doxorubicin metabolic process (GO:0044598) | 3.79827482 |
| 75 | daunorubicin metabolic process (GO:0044597) | 3.79827482 |
| 76 | polyketide metabolic process (GO:0030638) | 3.79827482 |
| 77 | coenzyme catabolic process (GO:0009109) | 3.79747284 |
| 78 | * acute inflammatory response (GO:0002526) | 3.76947641 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.75614049 |
| 80 | drug metabolic process (GO:0017144) | 3.74943051 |
| 81 | primary alcohol catabolic process (GO:0034310) | 3.73407583 |
| 82 | oxaloacetate metabolic process (GO:0006107) | 3.70534954 |
| 83 | regulation of cholesterol homeostasis (GO:2000188) | 3.69602293 |
| 84 | response to dietary excess (GO:0002021) | 3.69482560 |
| 85 | lipid storage (GO:0019915) | 3.69379665 |
| 86 | cytolysis (GO:0019835) | 3.68557676 |
| 87 | NADH metabolic process (GO:0006734) | 3.66868510 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 3.66732423 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 3.64458279 |
| 90 | negative regulation of sterol transport (GO:0032372) | 3.63922111 |
| 91 | negative regulation of cholesterol transport (GO:0032375) | 3.63922111 |
| 92 | pantothenate metabolic process (GO:0015939) | 3.62027674 |
| 93 | amino-acid betaine metabolic process (GO:0006577) | 3.60853169 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60727986 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60727986 |
| 96 | regulation of protein glycosylation (GO:0060049) | 3.58346036 |
| 97 | regulation of plasminogen activation (GO:0010755) | 3.56746132 |
| 98 | cellular response to cadmium ion (GO:0071276) | 3.52439466 |
| 99 | arginine metabolic process (GO:0006525) | 3.51697272 |
| 100 | regulation of cholesterol metabolic process (GO:0090181) | 3.49567482 |
| 101 | lysine metabolic process (GO:0006553) | 3.49543167 |
| 102 | lysine catabolic process (GO:0006554) | 3.49543167 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.49325607 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.49325607 |
| 105 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.47634427 |
| 106 | cellular response to zinc ion (GO:0071294) | 3.44253714 |
| 107 | retinol metabolic process (GO:0042572) | 3.44004554 |
| 108 | cellular amino acid catabolic process (GO:0009063) | 3.42569681 |
| 109 | triglyceride metabolic process (GO:0006641) | 3.41446367 |
| 110 | drug catabolic process (GO:0042737) | 3.41265411 |
| 111 | cellular ketone body metabolic process (GO:0046950) | 3.40974363 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.40777076 |
| 113 | cholesterol homeostasis (GO:0042632) | 3.40061970 |
| 114 | response to phenylpropanoid (GO:0080184) | 3.39713166 |
| 115 | regulation of lipoprotein metabolic process (GO:0050746) | 3.39685819 |
| 116 | plasma lipoprotein particle clearance (GO:0034381) | 3.39371784 |
| 117 | biotin metabolic process (GO:0006768) | 3.36692413 |
| 118 | brown fat cell differentiation (GO:0050873) | 3.36363042 |
| 119 | glutamate metabolic process (GO:0006536) | 3.36007746 |
| 120 | sterol homeostasis (GO:0055092) | 3.35511279 |
| 121 | cellular modified amino acid catabolic process (GO:0042219) | 3.34598033 |
| 122 | imidazole-containing compound metabolic process (GO:0052803) | 3.33865902 |
| 123 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.33093030 |
| 124 | positive regulation of lipid catabolic process (GO:0050996) | 3.33009542 |
| 125 | regulation of humoral immune response (GO:0002920) | 3.32863931 |
| 126 | phospholipid homeostasis (GO:0055091) | 3.29064079 |
| 127 | negative regulation of blood coagulation (GO:0030195) | 3.27907380 |
| 128 | negative regulation of hemostasis (GO:1900047) | 3.27907380 |
| 129 | ovulation from ovarian follicle (GO:0001542) | 3.25747714 |
| 130 | exogenous drug catabolic process (GO:0042738) | 3.24903388 |
| 131 | regulation of triglyceride metabolic process (GO:0090207) | 3.22995807 |
| 132 | cholesterol efflux (GO:0033344) | 3.22554391 |
| 133 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.21647471 |
| 134 | iron coordination entity transport (GO:1901678) | 3.21402703 |
| 135 | acylglycerol metabolic process (GO:0006639) | 3.20451636 |
| 136 | low-density lipoprotein particle remodeling (GO:0034374) | 3.20105548 |
| 137 | negative regulation of lipase activity (GO:0060192) | 3.18707889 |
| 138 | flavonoid metabolic process (GO:0009812) | 3.16771078 |
| 139 | neutral lipid metabolic process (GO:0006638) | 3.15048319 |
| 140 | cofactor catabolic process (GO:0051187) | 3.14790643 |
| 141 | positive regulation of lipid storage (GO:0010884) | 3.14679606 |
| 142 | negative regulation of complement activation (GO:0045916) | 3.12188658 |
| 143 | regulation of sterol transport (GO:0032371) | 3.10628587 |
| 144 | regulation of cholesterol transport (GO:0032374) | 3.10628587 |
| 145 | negative regulation of coagulation (GO:0050819) | 3.10138598 |
| 146 | cellular response to leptin stimulus (GO:0044320) | 3.07956114 |
| 147 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.06468884 |
| 148 | glycine metabolic process (GO:0006544) | 3.05457804 |
| 149 | retinal metabolic process (GO:0042574) | 3.05424131 |
| 150 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.05336194 |
| 151 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.05287771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.85863005 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.68127693 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.89006121 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.65910168 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.20126676 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77648662 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.28204329 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.15378015 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.66437552 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.75388389 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.32427803 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.10722680 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92268368 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91761493 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.79967790 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79427821 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78894825 |
| 18 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.74943164 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74876600 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67069266 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59641929 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.56314555 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54506218 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.54278285 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.52961277 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49317589 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42092859 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38326931 |
| 29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37465543 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36986490 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36880340 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.35390069 |
| 33 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.34272860 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31500604 |
| 35 | CJUN_26792858_Chip-Seq_BT549_Human | 1.31436088 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26228457 |
| 37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24170648 |
| 38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24170648 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.21586738 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21470049 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18578751 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17843018 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17445667 |
| 44 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17131461 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16497207 |
| 46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13926270 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13459242 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12628705 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12620094 |
| 50 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.09428650 |
| 51 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08578041 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06408408 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05307129 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99153340 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98986069 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90241058 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90112423 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90014767 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89992409 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88879577 |
| 61 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87754227 |
| 62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87315855 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85902002 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85823418 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85823418 |
| 66 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85160981 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83371238 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83281861 |
| 69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.83006590 |
| 70 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82646024 |
| 71 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82644922 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81701339 |
| 73 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.81134034 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80500072 |
| 75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78771266 |
| 76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78771266 |
| 77 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77681829 |
| 78 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76993562 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76880169 |
| 80 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.76686173 |
| 81 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76305738 |
| 82 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.75646291 |
| 83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.74939951 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74891831 |
| 85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73018756 |
| 86 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72448647 |
| 87 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.71508506 |
| 88 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71497178 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71255875 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71206165 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71050785 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.71018734 |
| 93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70515708 |
| 94 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.69929666 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 0.69726831 |
| 96 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69228373 |
| 97 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69093590 |
| 98 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.68646535 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68563086 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68511264 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67762923 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67465136 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.67416854 |
| 104 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67183431 |
| 105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.66736765 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66525516 |
| 107 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.66207118 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.65892195 |
| 109 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64580666 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64502538 |
| 111 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63218948 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63087574 |
| 113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.62718379 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.62625069 |
| 115 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.62096483 |
| 116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.61803065 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.60507126 |
| 118 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.58607172 |
| 119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.58561076 |
| 120 | ATF3_27146783_Chip-Seq_COLON_Human | 0.58451537 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58381654 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.58296075 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57952919 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57927130 |
| 125 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.57131373 |
| 126 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56362386 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56352986 |
| 128 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.56121080 |
| 129 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.56116674 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.55694280 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.55583341 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55239934 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.54244921 |
| 134 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.53517875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.46138437 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.43427507 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 6.15695016 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.68873645 |
| 5 | MP0005365_abnormal_bile_salt | 4.55749838 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.40052108 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.52298909 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.46414376 |
| 9 | MP0003252_abnormal_bile_duct | 3.32421402 |
| 10 | MP0005375_adipose_tissue_phenotype | 3.17278332 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.04261679 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.71093186 |
| 13 | MP0002822_catalepsy | 2.47300607 |
| 14 | MP0005083_abnormal_biliary_tract | 2.18962750 |
| 15 | MP0009115_abnormal_fat_cell | 2.17981186 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.14692985 |
| 17 | MP0009840_abnormal_foam_cell | 2.09807310 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.07807548 |
| 19 | MP0005332_abnormal_amino_acid | 2.07272702 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 1.90983967 |
| 21 | MP0003868_abnormal_feces_composition | 1.90906633 |
| 22 | MP0000003_abnormal_adipose_tissue | 1.90290696 |
| 23 | * MP0002118_abnormal_lipid_homeostasis | 1.85494010 |
| 24 | MP0003195_calcinosis | 1.84697248 |
| 25 | MP0003959_abnormal_lean_body | 1.80631151 |
| 26 | MP0000609_abnormal_liver_physiology | 1.77354995 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.76601746 |
| 28 | MP0002970_abnormal_white_adipose | 1.74906964 |
| 29 | MP0005670_abnormal_white_adipose | 1.73838883 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.72239195 |
| 31 | MP0005275_abnormal_skin_tensile | 1.69886715 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.68704290 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.63983370 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.61028643 |
| 35 | MP0005535_abnormal_body_temperature | 1.60736022 |
| 36 | MP0000604_amyloidosis | 1.57827518 |
| 37 | MP0004272_abnormal_basement_membrane | 1.56067761 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.44919039 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40971506 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.40877974 |
| 41 | MP0006138_congestive_heart_failure | 1.38678718 |
| 42 | MP0003828_pulmonary_edema | 1.37464586 |
| 43 | MP0003878_abnormal_ear_physiology | 1.30906975 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.30906975 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.25845815 |
| 46 | MP0005448_abnormal_energy_balance | 1.23046288 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.21671680 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.20815996 |
| 49 | MP0001879_abnormal_lymphatic_vessel | 1.18919292 |
| 50 | MP0003724_increased_susceptibility_to | 1.16238810 |
| 51 | MP0005164_abnormal_response_to | 1.15221615 |
| 52 | MP0002108_abnormal_muscle_morphology | 1.15034667 |
| 53 | MP0002796_impaired_skin_barrier | 1.14094668 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.11592926 |
| 55 | MP0003011_delayed_dark_adaptation | 1.10407232 |
| 56 | MP0002254_reproductive_system_inflammat | 1.06842649 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.06320662 |
| 58 | MP0000343_altered_response_to | 1.04394825 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.04157348 |
| 60 | MP0005452_abnormal_adipose_tissue | 1.02809691 |
| 61 | MP0009785_altered_susceptibility_to | 1.02010294 |
| 62 | MP0001873_stomach_inflammation | 1.01779729 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.00387693 |
| 64 | MP0005451_abnormal_body_composition | 0.98982128 |
| 65 | MP0003566_abnormal_cell_adhesion | 0.98808830 |
| 66 | MP0001881_abnormal_mammary_gland | 0.98665924 |
| 67 | MP0001764_abnormal_homeostasis | 0.97722683 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 0.96781905 |
| 69 | MP0000598_abnormal_liver_morphology | 0.93953449 |
| 70 | MP0008469_abnormal_protein_level | 0.93886566 |
| 71 | MP0009764_decreased_sensitivity_to | 0.92785718 |
| 72 | MP0000249_abnormal_blood_vessel | 0.91891237 |
| 73 | MP0002971_abnormal_brown_adipose | 0.90787422 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.90344703 |
| 75 | MP0000751_myopathy | 0.88689312 |
| 76 | MP0000858_altered_metastatic_potential | 0.88586371 |
| 77 | MP0009763_increased_sensitivity_to | 0.87763862 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 0.84661800 |
| 79 | MP0001663_abnormal_digestive_system | 0.84344535 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.83719051 |
| 81 | MP0009053_abnormal_anal_canal | 0.83543004 |
| 82 | MP0008872_abnormal_physiological_respon | 0.81554800 |
| 83 | * MP0009642_abnormal_blood_homeostasis | 0.81153113 |
| 84 | MP0008873_increased_physiological_sensi | 0.80956811 |
| 85 | MP0005166_decreased_susceptibility_to | 0.80416922 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.78507757 |
| 87 | MP0003866_abnormal_defecation | 0.78167591 |
| 88 | MP0002933_joint_inflammation | 0.77958091 |
| 89 | MP0002132_abnormal_respiratory_system | 0.75957939 |
| 90 | MP0000477_abnormal_intestine_morphology | 0.73837811 |
| 91 | MP0003300_gastrointestinal_ulcer | 0.72654135 |
| 92 | MP0004947_skin_inflammation | 0.72601774 |
| 93 | MP0005647_abnormal_sex_gland | 0.72311419 |
| 94 | MP0003279_aneurysm | 0.71947005 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.71770317 |
| 96 | MP0005266_abnormal_metabolism | 0.71079322 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.71041600 |
| 98 | MP0005381_digestive/alimentary_phenotyp | 0.70389166 |
| 99 | MP0005385_cardiovascular_system_phenoty | 0.70231529 |
| 100 | MP0001544_abnormal_cardiovascular_syste | 0.70231529 |
| 101 | MP0004130_abnormal_muscle_cell | 0.69945161 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.69049619 |
| 103 | MP0002098_abnormal_vibrissa_morphology | 0.66650940 |
| 104 | MP0000749_muscle_degeneration | 0.65614300 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.65062130 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.64554996 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.64117408 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.63321387 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.63004064 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.62889166 |
| 111 | MP0002060_abnormal_skin_morphology | 0.61162369 |
| 112 | MP0003690_abnormal_glial_cell | 0.60996110 |
| 113 | MP0001661_extended_life_span | 0.60250738 |
| 114 | MP0005165_increased_susceptibility_to | 0.59336320 |
| 115 | MP0003186_abnormal_redox_activity | 0.59216417 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.58914928 |
| 117 | MP0005023_abnormal_wound_healing | 0.58789217 |
| 118 | MP0000427_abnormal_hair_cycle | 0.58334738 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.57813087 |
| 120 | MP0003953_abnormal_hormone_level | 0.57697099 |
| 121 | MP0001756_abnormal_urination | 0.57536935 |
| 122 | MP0001664_abnormal_digestion | 0.57500023 |
| 123 | MP0003075_altered_response_to | 0.56615632 |
| 124 | MP0000759_abnormal_skeletal_muscle | 0.56113719 |
| 125 | MP0000579_abnormal_nail_morphology | 0.55951979 |
| 126 | MP0003879_abnormal_hair_cell | 0.55308520 |
| 127 | MP0003436_decreased_susceptibility_to | 0.54789917 |
| 128 | MP0003303_peritoneal_inflammation | 0.54732062 |
| 129 | MP0004087_abnormal_muscle_fiber | 0.53688339 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.53565506 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.53381656 |
| 132 | MP0006035_abnormal_mitochondrial_morpho | 0.52825792 |
| 133 | MP0000383_abnormal_hair_follicle | 0.52666586 |
| 134 | MP0001501_abnormal_sleep_pattern | 0.52040422 |
| 135 | MP0000627_abnormal_mammary_gland | 0.51907022 |
| 136 | MP0005334_abnormal_fat_pad | 0.51826681 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.51533006 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.50802321 |
| 139 | MP0009379_abnormal_foot_pigmentation | 0.50736605 |
| 140 | MP0005464_abnormal_platelet_physiology | 0.50432563 |
| 141 | MP0002638_abnormal_pupillary_reflex | 0.49063666 |
| 142 | MP0000377_abnormal_hair_follicle | 0.49049655 |
| 143 | MP0006036_abnormal_mitochondrial_physio | 0.47831325 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.46067598 |
| 145 | MP0003329_amyloid_beta_deposits | 0.45164692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.65608774 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.50966980 |
| 3 | Complement deficiency (HP:0004431) | 6.27220352 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 6.24998106 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.09744054 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.99445040 |
| 7 | Xanthomatosis (HP:0000991) | 5.90903770 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.75651427 |
| 9 | Spontaneous abortion (HP:0005268) | 5.21438618 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.94251060 |
| 11 | Acanthosis nigricans (HP:0000956) | 4.75145237 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 4.69180592 |
| 13 | Abnormality of complement system (HP:0005339) | 4.63547575 |
| 14 | Hypertriglyceridemia (HP:0002155) | 4.62494396 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.61340012 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48002037 |
| 17 | Malnutrition (HP:0004395) | 4.34918088 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.34140543 |
| 19 | Joint hemorrhage (HP:0005261) | 4.11544918 |
| 20 | Epidermoid cyst (HP:0200040) | 3.69385417 |
| 21 | Fat malabsorption (HP:0002630) | 3.69288077 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.68243522 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.65660376 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.57506575 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.53822804 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.49745824 |
| 27 | Hyperammonemia (HP:0001987) | 3.48104232 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.29461919 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.22860208 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.14727067 |
| 31 | Oligomenorrhea (HP:0000876) | 3.10115620 |
| 32 | Hyperglycinemia (HP:0002154) | 3.09802817 |
| 33 | Ketosis (HP:0001946) | 3.08362203 |
| 34 | Protrusio acetabuli (HP:0003179) | 3.03040683 |
| 35 | Amyloidosis (HP:0011034) | 3.02437069 |
| 36 | Gingival bleeding (HP:0000225) | 3.01374983 |
| 37 | Insulin resistance (HP:0000855) | 2.98361184 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.97231761 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 2.93604619 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.92377913 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.92129356 |
| 42 | Villous atrophy (HP:0011473) | 2.88262799 |
| 43 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.88262799 |
| 44 | Steatorrhea (HP:0002570) | 2.84962163 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.82893272 |
| 46 | Myocardial infarction (HP:0001658) | 2.70856810 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.69401176 |
| 48 | Increased serum pyruvate (HP:0003542) | 2.67975992 |
| 49 | Glomerulonephritis (HP:0000099) | 2.64281399 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.63542202 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.63542202 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.62831724 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.61470578 |
| 54 | Hyperglycinuria (HP:0003108) | 2.60627100 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.58101460 |
| 56 | Esophageal varix (HP:0002040) | 2.56991676 |
| 57 | Thrombophlebitis (HP:0004418) | 2.55278785 |
| 58 | Hyperbilirubinemia (HP:0002904) | 2.42639359 |
| 59 | Cholecystitis (HP:0001082) | 2.41411600 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.41411600 |
| 61 | Prostate neoplasm (HP:0100787) | 2.40763334 |
| 62 | Flat acetabular roof (HP:0003180) | 2.36892208 |
| 63 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.34065840 |
| 64 | Hemorrhage of the eye (HP:0011885) | 2.31773094 |
| 65 | Abnormality of glycolysis (HP:0004366) | 2.30054693 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.29623370 |
| 67 | Bone cyst (HP:0012062) | 2.28125884 |
| 68 | Gout (HP:0001997) | 2.27464698 |
| 69 | Skin nodule (HP:0200036) | 2.24608632 |
| 70 | Abnormal tarsal ossification (HP:0008369) | 2.23595102 |
| 71 | Increased purine levels (HP:0004368) | 2.23023005 |
| 72 | Hyperuricemia (HP:0002149) | 2.23023005 |
| 73 | Polygenic inheritance (HP:0010982) | 2.20892755 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.20521062 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20521062 |
| 76 | Alopecia of scalp (HP:0002293) | 2.20214999 |
| 77 | Vascular calcification (HP:0004934) | 2.19651487 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.19567978 |
| 79 | Hepatocellular carcinoma (HP:0001402) | 2.19437458 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.17895725 |
| 81 | Abdominal distention (HP:0003270) | 2.16304263 |
| 82 | Hyperglycemia (HP:0003074) | 2.14207279 |
| 83 | Neonatal hypoglycemia (HP:0001998) | 2.13312244 |
| 84 | Retinal atrophy (HP:0001105) | 2.12928266 |
| 85 | Late onset (HP:0003584) | 2.12423953 |
| 86 | Pustule (HP:0200039) | 2.10534554 |
| 87 | Abnormal cartilage morphology (HP:0002763) | 2.10325229 |
| 88 | Irritability (HP:0000737) | 2.10270785 |
| 89 | Pigmentary retinal degeneration (HP:0001146) | 2.10032325 |
| 90 | Ketoacidosis (HP:0001993) | 2.09708232 |
| 91 | Abnormal delivery (HP:0001787) | 2.08573701 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.07942061 |
| 93 | Menorrhagia (HP:0000132) | 2.07271836 |
| 94 | Joint swelling (HP:0001386) | 2.05310367 |
| 95 | Cholelithiasis (HP:0001081) | 2.05014083 |
| 96 | Hypophosphatemic rickets (HP:0004912) | 2.04185592 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.03607526 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.03369536 |
| 99 | Lethargy (HP:0001254) | 2.02179515 |
| 100 | Long foot (HP:0001833) | 2.01854277 |
| 101 | Spastic diplegia (HP:0001264) | 2.01735860 |
| 102 | Growth hormone excess (HP:0000845) | 2.00632028 |
| 103 | Hypochromic microcytic anemia (HP:0004840) | 2.00590338 |
| 104 | Mitral stenosis (HP:0001718) | 2.00134547 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00084430 |
| 106 | Ileus (HP:0002595) | 1.98821319 |
| 107 | Nephritis (HP:0000123) | 1.98764110 |
| 108 | Alkalosis (HP:0001948) | 1.98441313 |
| 109 | Axonal loss (HP:0003447) | 1.98315201 |
| 110 | Cardiovascular calcification (HP:0011915) | 1.97433513 |
| 111 | Cervical subluxation (HP:0003308) | 1.97233241 |
| 112 | Metaphyseal dysplasia (HP:0100255) | 1.93280601 |
| 113 | Back pain (HP:0003418) | 1.92027990 |
| 114 | Purpura (HP:0000979) | 1.91900268 |
| 115 | Abnormality of serum amino acid levels (HP:0003112) | 1.91137845 |
| 116 | Metabolic acidosis (HP:0001942) | 1.90831297 |
| 117 | Protuberant abdomen (HP:0001538) | 1.90766711 |
| 118 | Polycythemia (HP:0001901) | 1.90223128 |
| 119 | Neonatal onset (HP:0003623) | 1.89784953 |
| 120 | Lymphangioma (HP:0100764) | 1.88714996 |
| 121 | Atrioventricular block (HP:0001678) | 1.87989712 |
| 122 | Toxemia of pregnancy (HP:0100603) | 1.87739240 |
| 123 | Pancreatitis (HP:0001733) | 1.85876343 |
| 124 | Rickets (HP:0002748) | 1.85538142 |
| 125 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.85198972 |
| 126 | Abnormal eating behavior (HP:0100738) | 1.81873054 |
| 127 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.81020648 |
| 128 | Reduced antithrombin III activity (HP:0001976) | 1.80934833 |
| 129 | Abnormal hemoglobin (HP:0011902) | 1.78196136 |
| 130 | Increased mean platelet volume (HP:0011877) | 1.76007340 |
| 131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75071843 |
| 132 | Nausea (HP:0002018) | 1.74885343 |
| 133 | Vascular tortuosity (HP:0004948) | 1.74194493 |
| 134 | Subcapsular cataract (HP:0000523) | 1.73666594 |
| 135 | Hydroxyprolinuria (HP:0003080) | 1.70292114 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.70292114 |
| 137 | Prominent supraorbital ridges (HP:0000336) | 1.69614244 |
| 138 | Ectopia lentis (HP:0001083) | 1.64013332 |
| 139 | Abnormality of carpal bone ossification (HP:0006257) | 1.63993427 |
| 140 | Muscle fiber splitting (HP:0003555) | 1.63389238 |
| 141 | Glomerulosclerosis (HP:0000096) | 1.62403496 |
| 142 | Aortic aneurysm (HP:0004942) | 1.61820627 |
| 143 | Striae distensae (HP:0001065) | 1.58045266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 8.27944709 |
| 2 | PIK3CA | 8.16316335 |
| 3 | MAP3K2 | 3.84738949 |
| 4 | KSR2 | 3.64257099 |
| 5 | TGFBR2 | 3.24769497 |
| 6 | MET | 3.07789596 |
| 7 | ERN1 | 3.06889272 |
| 8 | RIPK1 | 2.87335589 |
| 9 | TAOK3 | 2.74465327 |
| 10 | MAP2K2 | 2.72337431 |
| 11 | DDR2 | 2.65810169 |
| 12 | ARAF | 2.62565226 |
| 13 | FRK | 2.59062242 |
| 14 | FGFR4 | 2.27315802 |
| 15 | LATS2 | 2.22599471 |
| 16 | TIE1 | 2.16729505 |
| 17 | BCKDK | 2.13005337 |
| 18 | MAP3K13 | 1.99267970 |
| 19 | MOS | 1.90096279 |
| 20 | TRPM7 | 1.83321132 |
| 21 | GRK5 | 1.71698161 |
| 22 | ERBB4 | 1.71586242 |
| 23 | NME1 | 1.67237750 |
| 24 | MAP2K1 | 1.62615996 |
| 25 | MAPKAPK3 | 1.61770896 |
| 26 | MAP3K14 | 1.43515239 |
| 27 | MAP3K6 | 1.42864074 |
| 28 | PINK1 | 1.39537376 |
| 29 | MAP3K1 | 1.38651222 |
| 30 | PDGFRA | 1.37128012 |
| 31 | MAP3K9 | 1.34985206 |
| 32 | SIK1 | 1.26688946 |
| 33 | CAMK1 | 1.14881302 |
| 34 | ADRBK1 | 1.14844307 |
| 35 | EPHA3 | 1.10857504 |
| 36 | CAMK2D | 1.07175472 |
| 37 | MUSK | 1.06037856 |
| 38 | MAPK11 | 1.03652975 |
| 39 | EPHB1 | 1.00406229 |
| 40 | ILK | 0.98046179 |
| 41 | RET | 0.95190295 |
| 42 | GRK6 | 0.94836678 |
| 43 | PTK6 | 0.90900292 |
| 44 | JAK2 | 0.89919980 |
| 45 | NLK | 0.87073696 |
| 46 | TAOK1 | 0.84008016 |
| 47 | TBK1 | 0.82674848 |
| 48 | PTK2 | 0.82661043 |
| 49 | CAMK1D | 0.82387023 |
| 50 | CDK6 | 0.81471848 |
| 51 | INSRR | 0.81332257 |
| 52 | PIK3CG | 0.76930323 |
| 53 | MYLK | 0.76349625 |
| 54 | TRIB3 | 0.74054308 |
| 55 | EPHB2 | 0.73814988 |
| 56 | CAMKK2 | 0.71795284 |
| 57 | MAP3K3 | 0.70952893 |
| 58 | IRAK3 | 0.70369466 |
| 59 | PDGFRB | 0.69204629 |
| 60 | CDC42BPA | 0.64947155 |
| 61 | STK24 | 0.64558900 |
| 62 | MAP3K8 | 0.64407666 |
| 63 | ERBB2 | 0.63427957 |
| 64 | STK38 | 0.61851423 |
| 65 | MAPK7 | 0.61408690 |
| 66 | MAP2K4 | 0.60565950 |
| 67 | STK38L | 0.60424451 |
| 68 | PRKG1 | 0.58062815 |
| 69 | MAP2K3 | 0.57639961 |
| 70 | KDR | 0.57366467 |
| 71 | PIM2 | 0.56016982 |
| 72 | TYK2 | 0.55198894 |
| 73 | MAP3K11 | 0.54118045 |
| 74 | EEF2K | 0.52999581 |
| 75 | LRRK2 | 0.52210702 |
| 76 | MAP3K12 | 0.50268360 |
| 77 | NTRK1 | 0.50121986 |
| 78 | CAMK2G | 0.48115744 |
| 79 | CDK9 | 0.45881459 |
| 80 | DAPK2 | 0.45858779 |
| 81 | PDK1 | 0.44209779 |
| 82 | PAK4 | 0.43241788 |
| 83 | IKBKE | 0.42823751 |
| 84 | GRK1 | 0.42531013 |
| 85 | PKN2 | 0.42519624 |
| 86 | TAOK2 | 0.41946977 |
| 87 | PRKAA2 | 0.41639507 |
| 88 | ABL2 | 0.41232439 |
| 89 | ABL1 | 0.40738169 |
| 90 | JAK1 | 0.40360949 |
| 91 | MAP3K7 | 0.40136434 |
| 92 | LATS1 | 0.39751671 |
| 93 | IRAK1 | 0.39227904 |
| 94 | AKT2 | 0.37948818 |
| 95 | MTOR | 0.37835896 |
| 96 | MAPK15 | 0.36752324 |
| 97 | PRPF4B | 0.36594988 |
| 98 | MAPK4 | 0.35883847 |
| 99 | PRKG2 | 0.35800465 |
| 100 | MAPK3 | 0.34600000 |
| 101 | PRKCZ | 0.34187702 |
| 102 | RIPK4 | 0.34033418 |
| 103 | KIT | 0.32446018 |
| 104 | LMTK2 | 0.31760834 |
| 105 | BRAF | 0.31575890 |
| 106 | GRK7 | 0.31403012 |
| 107 | PRKD1 | 0.30108148 |
| 108 | PRKACG | 0.29426686 |
| 109 | CSK | 0.28854272 |
| 110 | EPHA2 | 0.28838956 |
| 111 | INSR | 0.27548410 |
| 112 | ACVR1B | 0.27287463 |
| 113 | PDK2 | 0.27245470 |
| 114 | MELK | 0.26945424 |
| 115 | MAPK12 | 0.25925572 |
| 116 | SRC | 0.24043632 |
| 117 | GSK3A | 0.23908664 |
| 118 | FGFR2 | 0.23391182 |
| 119 | IGF1R | 0.21940391 |
| 120 | FER | 0.21110809 |
| 121 | RPS6KB2 | 0.20498336 |
| 122 | PRKCA | 0.19456027 |
| 123 | PDPK1 | 0.18859833 |
| 124 | LYN | 0.17177479 |
| 125 | IRAK2 | 0.15296258 |
| 126 | NEK9 | 0.15075028 |
| 127 | FGFR3 | 0.14864780 |
| 128 | SGK223 | 0.14789927 |
| 129 | SGK494 | 0.14789927 |
| 130 | DAPK3 | 0.14735098 |
| 131 | SGK3 | 0.13491174 |
| 132 | PKN1 | 0.13148826 |
| 133 | PTK2B | 0.12301035 |
| 134 | CHUK | 0.12286433 |
| 135 | PAK2 | 0.11779893 |
| 136 | CAMK2B | 0.09876195 |
| 137 | CSNK1E | 0.08585276 |
| 138 | ITK | 0.08059122 |
| 139 | TESK1 | 0.07540171 |
| 140 | WNK1 | 0.07101788 |
| 141 | PRKCQ | 0.06107824 |
| 142 | PRKAA1 | 0.06103111 |
| 143 | PRKACB | 0.06075706 |
| 144 | BMX | 0.05716221 |
| 145 | STK11 | 0.04770107 |
| 146 | MAP2K6 | 0.04358217 |
| 147 | MAP3K10 | 0.04302651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.19354227 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.31424420 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26933344 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97738506 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.97254907 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86951585 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 2.57978009 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54427541 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.48248711 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.42200350 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.32076385 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.28226583 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24329458 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17849541 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11963500 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10560251 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.09441241 |
| 18 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.06551815 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04012507 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85592293 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84051298 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83768757 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83039225 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79144549 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76968378 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.71951675 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69689082 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58959986 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53185386 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49935255 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49336046 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45365302 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39451891 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33643897 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28570305 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28382493 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26534104 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26353247 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25290101 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23206442 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 1.21273114 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.20942400 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17792954 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14035140 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11938876 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10879265 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10289877 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08427013 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05355481 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 1.02291505 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00887297 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00634699 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99790066 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96550276 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94140967 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92866319 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92269703 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91205908 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88735521 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84870392 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83000076 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.78013216 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76188981 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68206874 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65970947 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63963021 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63681849 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58029910 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56386780 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53946767 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53510699 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40995888 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38261917 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.38249746 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36683585 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35519763 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34273182 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.33788199 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32681049 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32582159 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30298590 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25130328 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24201084 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.23966201 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22629946 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.19594875 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.19323528 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.18026971 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16454837 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16286639 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.16085884 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.12388625 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10239700 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.10230887 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.08282110 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07799277 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.07717610 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.07268227 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.06471061 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.05758703 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.05081748 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.03997298 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.02773141 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02767218 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.02659371 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02498499 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.00565992 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.00509564 |
| 109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.0652174 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | -0.0523692 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0491610 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0425026 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0409672 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0302314 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0246831 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0137422 |

